SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-07-069339
Filing Date
2007-12-27
Accepted
2007-12-27 16:10:31
Documents
1
Period of Report
2007-12-27

Document Format Files

Seq Description Document Type Size
1 v098248_ex.html 3  
1 v098248_ex.xml 3 2720
  Complete submission text file 0001144204-07-069339.txt   4674
Mailing Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 460 LA JOLLA CA 92037 (858) 457-5300
TRANSDEL PHARMACEUTICALS INC (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TRANSDEL PHARMACEUTICALS, INC. 4225 EXECUTIVE SQUARE, SUITE 460 LA JOLLA CA 92037
Business Address (858) 457-5300
Lomoro John T (Reporting) CIK: 0001421169 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52998 | Film No.: 071329238